taurine has been researched along with Schizophrenia in 17 studies
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Excerpt | Relevance | Reference |
---|---|---|
"Taurine was mostly devoid of effects and did not counteract NMDA antagonism in mice or zebrafish." | 5.91 | Effects of Taurine in Mice and Zebrafish Behavioral Assays With Translational Relevance to Schizophrenia. ( Bastos, LM; Benvenutti, R; Gallas-Lopes, M; Giongo, FK; Herrmann, AP; Rosa, AR; Sachett, A, 2023) |
"Schizophrenia is a life disabling, multisystem neuropsychiatric disease mostly derived from complex epigenetic-mediated neurobiological changes causing behavioural deficits." | 5.91 | Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice. ( Agu, GO; Ajayi, AM; Akaenyi, DE; Ben-Azu, B; Chijioke, BS; Chilaka, KC; Edigbue, NL; Esiekpe, UV; Jarikre, TA; Nwangwa, KE; Ofili, EC; Omonyeme, MG; Ozege, CB; Uruaka, CI; Warekoromor, EB, 2023) |
"Schizophrenia is noted for the remarkably high prevalence of substance use disorders (SUDs) including nicotine (>85%), alcohol and stimulants." | 2.43 | Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms. ( Coyle, JT, 2006) |
"Taurine was mostly devoid of effects and did not counteract NMDA antagonism in mice or zebrafish." | 1.91 | Effects of Taurine in Mice and Zebrafish Behavioral Assays With Translational Relevance to Schizophrenia. ( Bastos, LM; Benvenutti, R; Gallas-Lopes, M; Giongo, FK; Herrmann, AP; Rosa, AR; Sachett, A, 2023) |
"Schizophrenia is a life disabling, multisystem neuropsychiatric disease mostly derived from complex epigenetic-mediated neurobiological changes causing behavioural deficits." | 1.91 | Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice. ( Agu, GO; Ajayi, AM; Akaenyi, DE; Ben-Azu, B; Chijioke, BS; Chilaka, KC; Edigbue, NL; Esiekpe, UV; Jarikre, TA; Nwangwa, KE; Ofili, EC; Omonyeme, MG; Ozege, CB; Uruaka, CI; Warekoromor, EB, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 3 (17.65) | 2.80 |
Authors | Studies |
---|---|
Giongo, FK | 1 |
Gallas-Lopes, M | 1 |
Benvenutti, R | 1 |
Sachett, A | 1 |
Bastos, LM | 1 |
Rosa, AR | 1 |
Herrmann, AP | 1 |
Ben-Azu, B | 1 |
Uruaka, CI | 1 |
Ajayi, AM | 1 |
Jarikre, TA | 1 |
Nwangwa, KE | 1 |
Chilaka, KC | 1 |
Chijioke, BS | 1 |
Omonyeme, MG | 1 |
Ozege, CB | 1 |
Ofili, EC | 1 |
Warekoromor, EB | 1 |
Edigbue, NL | 1 |
Esiekpe, UV | 1 |
Akaenyi, DE | 1 |
Agu, GO | 1 |
Parksepp, M | 1 |
Leppik, L | 1 |
Koch, K | 1 |
Uppin, K | 1 |
Kangro, R | 1 |
Haring, L | 1 |
Vasar, E | 1 |
Zilmer, M | 1 |
Sekar, S | 1 |
Grandjean, J | 1 |
Garnell, JF | 1 |
Willems, R | 1 |
Duytschaever, H | 1 |
Seramani, S | 1 |
Su, H | 1 |
Ver Donck, L | 1 |
Bhakoo, KK | 1 |
Samuelsson, M | 1 |
Skogh, E | 1 |
Lundberg, K | 1 |
Vrethem, M | 1 |
Öllinger, K | 1 |
Paz, RD | 1 |
Tardito, S | 1 |
Atzori, M | 1 |
Tseng, KY | 1 |
Winter, C | 1 |
Djodari-Irani, A | 1 |
Sohr, R | 1 |
Morgenstern, R | 1 |
Feldon, J | 1 |
Juckel, G | 1 |
Meyer, U | 1 |
Tek, C | 1 |
Srihari, V | 1 |
Tek, E | 1 |
Ralevski, E | 1 |
O'Brien, E | 1 |
Jane, JS | 1 |
Dean, E | 1 |
Dwan, R | 1 |
Petrakis, I | 1 |
Coyle, JT | 1 |
Green, AI | 2 |
Drake, RE | 1 |
Brunette, MF | 2 |
Noordsy, DL | 2 |
O'Keefe, C | 1 |
Do, KQ | 1 |
Lauer, CJ | 1 |
Schreiber, W | 1 |
Zollinger, M | 1 |
Gutteck-Amsler, U | 1 |
Cuénod, M | 1 |
Holsboer, F | 1 |
Fekkes, D | 2 |
Pepplinkhuizen, L | 2 |
Verheij, R | 1 |
Bruinvels, J | 2 |
Beaton, JM | 1 |
Korpi, ER | 1 |
Kaufmann, CA | 1 |
Marnela, KM | 1 |
Weinberger, DR | 1 |
4 reviews available for taurine and Schizophrenia
Article | Year |
---|---|
Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.
Topics: Acamprosate; Age of Onset; Antipsychotic Agents; Glutamic Acid; Humans; Neurosciences; Psychopharmac | 2008 |
Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms.
Topics: Acamprosate; Alcohol Deterrents; Animals; Antipsychotic Agents; Clozapine; Diagnostic Imaging; Gluta | 2006 |
Substance abuse and schizophrenia: pharmacotherapeutic intervention.
Topics: Acamprosate; Alcohol Deterrents; Antipsychotic Agents; Clozapine; Disulfiram; Drug Interactions; Hum | 2008 |
Methylation & schizophrenia.
Topics: Amines; Amino Acids; Animals; Behavior, Animal; Catecholamines; Cats; Cystathionine; Cysteine; Dihyd | 1975 |
1 trial available for taurine and Schizophrenia
Article | Year |
---|---|
Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Cognition; Double-Blind Method; Femal | 2011 |
12 other studies available for taurine and Schizophrenia
Article | Year |
---|---|
Effects of Taurine in Mice and Zebrafish Behavioral Assays With Translational Relevance to Schizophrenia.
Topics: Animals; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Mice; Mice, Inbred C57BL; N-Methyla | 2023 |
Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.
Topics: Amino Acids; Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Dopamine; Interleukin | 2023 |
Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease.
Topics: Adult; Amino Acids; Antipsychotic Agents; Asparagine; Aspartic Acid; Biogenic Amines; Chromatography | 2020 |
Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy.
Topics: Anhedonia; Animals; Choline; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; | 2019 |
Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia.
Topics: Administration, Oral; Adult; Antioxidants; Antipsychotic Agents; Benzodiazepines; Case-Control Studi | 2013 |
Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Brain Diseases; Chromatography, High Press | 2009 |
Successful acamprosate treatment of alcohol dependence in schizophrenia.
Topics: Acamprosate; Aged; Alcohol Deterrents; Alcoholism; Comorbidity; Female; Humans; Schizophrenia; Tauri | 2008 |
Schizophrenia and co-occurring substance use disorder.
Topics: Acamprosate; Adult; Alcohol-Related Disorders; Antipsychotic Agents; Comorbidity; Diagnosis, Dual (P | 2007 |
gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders.
Topics: Adult; Aging; Chromatography, High Pressure Liquid; Dipeptides; Discriminant Analysis; Disease Progr | 1995 |
Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis.
Topics: Adult; Bipolar Disorder; Diagnosis, Differential; Female; Humans; Male; Methionine; Middle Aged; Psy | 1994 |
Cerebrospinal fluid amino acid concentrations in chronic schizophrenia.
Topics: Adult; Aged; Alanine; Amino Acids; Chronic Disease; Female; Glutamates; Glutamic Acid; Glutamine; Gl | 1987 |
Derangement of one-carbon metabolism in episodic schizoaffective psychoses.
Topics: Bipolar Disorder; Carbolines; Carbon; Glycine; Humans; Schizophrenia; Serine; Taurine | 1988 |